Nyfosa

Share Issue/Capital Change • Feb 17, 2020

Press release February 17, 2020

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND OR THE UNITED STATES OF AMERICA, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.

Nyfosa completes a directed issue of 6.46 million shares, raising proceeds of SEK 601 million

The board of directors of Nyfosa AB ("Nyfosa or the "Company") has, based on the authorization granted by the annual general meeting on May 9, 2019, resolved on a directed issue of 6,462,824 shares at a price of SEK 93 per share (the "Share issue"). The price has been determined through an accelerated book building procedure and corresponds to a discount of approximately 3 percent in relation to the closing price on Nasdaq Stockholm on February 17, 2020. Nyfosa receives around SEK 601 million before transaction costs through the Share issue.

The Share issue was directed to selected Swedish and international institutional investors, among others Bell Rock Capital Management, Carnegie Fonder, Handelsbanken Fonder, Länsförsäkringar Fastighetsfond, Odin Fonder and Swedbank Robur. Nyfosa intends to use the proceeds from the Share issue to maintain the Company's stable capital structure and create financial readiness for new business opportunities. The reason for deviating from the pre-emptive rights of existing shareholders was to complete an equity raise in a time and cost efficient manner, thereby enabling the Company to continue acting swiftly on new business opportunities according to its strategy as a growth oriented, transaction-based and opportunistic property company.

Following the Share issue, the total number of shares in Nyfosa will increase with 6,462,824, from 167,728,249 to 174,191,073. The share capital will increase with SEK 3,231,412, from SEK 83,864,124.50 to SEK 87,095,536.50. The Share issue entails a dilution of approximately 3.7 percent, based on the total amount of shares in Nyfosa after the Share issue.

ABG Sundal Collier has acted as sole bookrunner and Advokatfirman Cederquist has acted as legal advisor in the Share issue.

For more information, please contact:

Jens Engwall, CEO, jens.engwall@nyfosa.se, tel: +46 706 906 550 Johan Ejerhed, Head of Finance, johan.ejerhed@nyfosa.se, tel: +46 703 939 887

The information was prior to this release inside information and is information that Nyfosa AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication through the agency of the contact persons set out above on February 17, 2020 at 11.10 p.m. CET.

Nyfosa AB Visiting address Hästholmsvägen 28, 131 30 Nacka Phone +46 8 406 64 00 Postal address Box 4044, 131 04 Nacka E-mail info@nyfosa.se

About Nyfosa

Nyfosa is a transaction-based and opportunistic property company. The company's business concept is based on active participation in the Swedish transaction market combined with an investment strategy that can be flexible to the property market. The goal is to develop and add value to a growing property portfolio while generating sustained high returns. At present, Nyfosa is focusing primarily on commercial properties in Sweden. As of December 31, 2019, Nyfosa owned commercial properties with a total property value of approximately SEK 19.6 billion. The company's stock is listed on Nasdaq Stockholm since November 2018. Read more at www.nyfosa.se.

Important information

Release, announcement or distribution of this press release may, in certain jurisdictions, be subject to restrictions according to law and people in those jurisdictions, in which this press release has been announced or distributed, should inform themselves of and follow such legal restrictions. This press release does not constitute an offer, or a solicitation of any offer, to buy or subscribe for any securities in Nyfosa in any jurisdiction.

This press release does not constitute or form part of an offer or solicitation to purchase or subscribe for securities in the United States. The securities referred to herein may not be sold in the United States absent registration or an exemption from registration under the US Securities Act of 1933, as amended. The information in this press release may not be announced, published or distributed to the United States, Australia, Canada, Hong Kong, Japan, New Zealand, Singapore, South Africa, Switzerland or in any other jurisdiction where the announcement, publication or distribution of the information would not comply with applicable laws and regulations.

This press release is not a prospectus. Nyfosa has not authorized any offer to the public of shares or rights in any member state of the EEA and no prospectus has been prepared or will be prepared in connection with the directed new share issue.